Blood Pressure Sensor of Watch-type Device With ECG Technology
NCT ID: NCT05196048
Last Updated: 2022-01-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2021-09-21
2022-09-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-contact Blood Pressure and SpO2 Measurement Based on Image Sensor
NCT06204822
A Multi-Center Prospective Open Label Study of a Web-based Application for Pulse Rate in Adult Patients
NCT05853380
The VISION-Acute Study
NCT04589923
Data Collection of Arterial Line Waveform and BP Values
NCT04510753
Smartphone Application-Based Vital Sign Monitors
NCT02482779
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No Intervention
No Intervention
No Intervention
No Intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No Intervention
No Intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
(1.1) The first group-High Range: At least 17 subjects over 22 years old with systolic blood pressure exceeding 140mmHg and diastolic blood pressure exceeding 90mmHg.
(1.2) The second group-Middle Range: at least 17 subjects over 22 years old with systolic blood pressure ranging from 110mmHg to 140mmHg and diastolic blood pressure ranging from 60mmHg to 90mmHg.
(1.3) The third group-Low Range: at least 17 subjects over 22 years old with systolic blood pressure lower than 110mmHg and diastolic blood pressure lower than 60mmHg.
Exclusion Criteria
* Arrhythmia
* Prior heart failure or heart attack
* Peripheral vascular disease or compromised circulation
* Valvular disease (diseases concerning the aortic valve)
* Cardiomyopathy
* Other known cardiovascular disease
* End-stage Renal Disease (ESRD)
* Diabetes
* Neurological disorder (for example, tremors)
* Clotting disorder or you are taking prescribed blood thinners
* Tattoo(s) on the wrist where you will wear the ASUS VivoWatch SP
22 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
China Medical University, Taiwan
OTHER
ASUSTek Computer INC.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yeh-Pang Chen, MDPHD
Role: PRINCIPAL_INVESTIGATOR
China Medical University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
China Medical University Hsinchu Hospital
Hsinchu, No. 199, Sec. 1, Xinglong Rd., Zhubei City, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMUH110-REC2-162
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.